期刊文献+

^(18)F-FDG PET-CT对多发性骨髓瘤的诊断价值 被引量:2

Value of 18F-FDG PET-CT in diagnosing multiple myeloma
下载PDF
导出
摘要 目的探讨18F-FDG PET-CT对多发性骨髓瘤(MM)的诊断价值。方法回顾分析经病理证实的27例MM患者的PET-CT资料,分别记录病灶骨质破坏的部位并按骨质破坏形态进行分类,同时测量其最大SUV值(SUVmax)。结果 27例MM患者中有26例PET-CT检出病灶(阳性率为96.3%),共检出病灶354个。PET和CT同时检出60.2%(213/354)的病灶,34处病灶仅在PET检出(34/354,9.6%),而107处病灶仅在CT检出(107/354,30.2%)。PET-CT表现分三型:①骨质疏松型(4例),表现为骨质密度减低,骨皮质变薄或断续不连,可合并胸腰椎压缩骨折,肋骨病理性骨折,PET示轻度代谢异常增高,SUVmax均值为3.5±1.0。②骨质破坏型(20例),表现为骨质破坏、病理性骨折、软组织肿块等,PET示大部分为中低代谢,SUVmax均值为3.1±1.0,合并软组织肿块时为高代谢,SUVmax均值为5.3±1.7。③骨质硬化型(3例),表现为骨质密度增高,破坏与硬化混合存在或骨质破坏周围有硬化缘,PET示轻度代谢异常增高,SUVmax均值为3.5±1.2。结论 PET-CT对于MM的诊断及评价全身累及范围具有一定价值。 Objective To investigate the value of 18F-fluorodeoxyglucose(18F-FDG) PET-CT in diagnosing multiple myeloma(MM).Methods The PET-CT findings of 27 patients with MM proved pathologically were retrospectively analyzed.Destructive site of bone lesions were recorded and classified according to the damage patterns.The maximum standard uptake values(SUV max) were measured.Results 26 of 27(96.3%) patients were confirmed by PET-CT.Total 354 lesions were detected.The positive rate was 60.2%(213/354) both by PET and CT.34 lesions were detected by PET(34/354,9.6%) and 107 lesions in CT(107/354,30.2%),respectively.The lesions were classified into 3 types according to theirs manifestation in PET-CT.① Type osteoporosis(4 cases): bone density decreased and bone cortex became thinner or discontinuous,combined with thoracolumbar vertebral compression fractures or pathologic fractures of ribs.PET showed increased mild metabolic abnormalities,the mean of SUV max was of 3.5±1.0.②Type bone destruction(20 cases): bone was destroyed or appeared as pathological fracture with soft tissue mass,etc.PET showed increased low to mild metabolic abnormalities,the mean of SUV max was 3.1±1.0,it would be higher if when soft tissue mass was combined,that was 5.3±1.7.③ Type bone sclerosis(3 cases): bone density increased and mixed destruction and sclerosis appeared in lesions.Sclerosis margin could be found around the destructions.PET showed increased mild metabolic abnormalities,the mean of SUV max was 3.5±1.2.Conclusion PET-CT has a certain value both in diagnosis of MM and evaluation of systemic involvement.
出处 《实用医学影像杂志》 2012年第2期104-107,共4页 Journal of Practical Medical Imaging
关键词 多发性骨髓瘤 体层摄影术 发射型计算机 脱氧葡萄糖 Multiple myeloma Tomography emission computed Deoxyglucose
  • 相关文献

参考文献9

  • 1姚树展,侯中煜,周存升.多发性骨髓瘤的影像学诊断[J].医学影像学杂志,2010,20(6):905-907. 被引量:23
  • 2任媛,王莉莉,郑永明.原发灶不明的骨转移癌核素骨显像结果分析[J].长治医学院学报,2007,21(6):453-454. 被引量:4
  • 3柳伟坤,李向东,李兴耀,王欣璐,全江涛,刘羽,欧阳习,周崝,尹吉林.多发性骨髓瘤的^(18)F-FDG PET/CT诊断价值[J].中国医学影像学杂志,2010,18(1):89-92. 被引量:11
  • 4叶香华,吴湖炳,王全师,陈龙华,周文兰,李洪生,张冬萍,王丽娟.^(18)F-FDG PET/CT诊断多发性骨髓瘤[J].中国医学影像技术,2009,25(5):897-900. 被引量:11
  • 5Nanni C,Zamagni E,Farsad M. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed muitiple myeloma preliminary results[J].European Journal of Nuclear Medicine and Molecular Imaging,2006,(05):525-531.
  • 6Fonti R,Salvatore B,Quarantelli M. 18F-FDG PET/CT,99mTc-MIBI and MRI in evaluation of patients with multiple myeloma[J].The Journal of Nuclear Medicine,2008,(02):195-200.
  • 7Bredella M A,Steinbach L,Caputo G. Value of FDG PET in the assessment of patients with multiple myeloma[J].American Journal of Roentgenology,2005,(04):1199-1204.
  • 8Schirrmeister H,Bommer M,Buck AK. Initial reults in the assessment of multiple myeloma using 18F-FDG PET[J].European Journal of Nuclear Medicine and Molecular Imaging,2002,(03):361-366.
  • 9Jadvar H,Coati PS. Diagnostic utility of FDG PET in multiple myeloma[J].Skeletal Radiology,2002,(12):690-694.

二级参考文献45

共引文献39

同被引文献24

  • 1张之南.血液病诊断及疗效标准[M].3版.北京:科学出版社,2008:1.
  • 2Davies MJ. Advancing access to myeloma treatment: administra- tion, side effects, and implications for survival [J]. ONS News, 2006, 21($): 11-12.
  • 3Hideshima T, Chauhan D, Richardson P, et al. NF-kappa B as a therapeutic target in multiple myeloma[J]. J Biol Chem, 2002, 277(19): 16639-16647.
  • 4Eslick R, Talaulikar D. Multiple myeloma: from diagnosis to tre- atment[J]. Aust Fam Physician, 2013, 42(10): 684-688.
  • 5Hong B, Hermann E J, Reuter C, et al. Outcome of surgical deco- mpression of spinal mass lesions in non-Hodgkin' s lymphomaand plasmacytoma[J]. Clin Neurol Neurosurg, 2013, 115 (12): 2476-2481.
  • 6Groff L, Zecca E, De Conno F, et al. The role of disodium pamidr- onate in the management of bone pain due to malignancy [J]. Palliat Med, 2011, 15(4): 297-307.
  • 7Fourney DR, Schomer DF, Nader R, et al. Percutaneous vertebr- oplasty and kyphoplasty for painful vertebral body fractures in cancer patients[J]. J Neurosurg, 2003, 98(1 Suppl): 21-30.
  • 8Lieberman IH, Dudeney S, Reinhardt MK, et al. Initial outcome and efficacy of "kyphonplasty" in the treatment of painful osteo- porotic vertebral compression fractures[J]. Spine(Phila Pa 1976), 2001, 26(14): 1631-1638.
  • 9Munk PL, Murphy KJ, Gangi A, et al. Fire and ice: percutaneous ablative therapies and cement injection in management of meta- static disease of the spine [J]. Semin Musculoskelet Radiol, 2011, 15(2): 125-134.
  • 10Pan J, Qian ZL, Sun ZY, et O1. Open kyphoplasty in the treatment of a painful vertebral lyric lesion with spinal cord compression caused by multiple myeloma: A case report[J]. Oncol Lett, 2013, 5(5): 1621-1624.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部